Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2012

Jan 26, 2012

34117_dirs_2012-01-26_99fac3d9-a93e-4ee1-a8bd-fc3e0cdffea3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-10-31

Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-05 Common Stock G 500000 Disposed 1169880 Direct
2011-02-22 Common Stock G 800000 Disposed 1169880 Direct
2011-05-25 Common Stock G 500000 Disposed 1169880 Direct

Footnotes

F1: Amount of securities beneficially owned represents shares held by Denis A. Krusos as of October 31, 2011 and excludes shares Mr. Krusos has the right to acquire upon exercise of stock options pursuant to CopyTele, Inc. stock incentive plans.

F2: Gift.